CUE logo

Cue Biopharma, Inc. (CUE)

Profile

Full Name

Cue Biopharma, Inc.

Ticker

NASDAQ: CUE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 2, 2018

Indexes

Not included

Website

https://www.cuebiopharma.com

Employees

41

Key Details

Price

$0.32(34.77%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$9.29M(69.16% YoY)

Annual EPS

-$0.72(34.88% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.32
    CUE price is $0.32

    30-Day Relative Volume

    7.27
    CUE 30-day relative volume is 7.27

    Price Performance

    Price 1-Day Change

    +34.77%
    CUE price is up +34.77% today

    Price YTD Change

    -70.2%
    CUE price is down -70.2% since January 1st

    Price 1-Year Change

    -69.93%
    CUE price is down -69.93% year-on-year

    Price 3-Year Change

    -88.19%
    CUE price is down -88.19% over the past 3 years

    Price Range

    Price All-Time High

    $31.69
    CUE price is currently -98.98% below its historical high of $31.69

    Price 3-Year Low

    $0.23
    CUE price is currently +41.22% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $25.57M
    CUE market cap is $25.57 million

    Market Cap 3-Year Change

    -78.39%
    CUE market cap is down -78.39% over the past 3 years

    Market Cap All-Time High

    $874.26M
    CUE market cap is currently -97.07% below its historical high of $874.26 million

    Market Cap Sector Percentile

    26.05%
    CUE market cap is higher than 26.05% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +24.29%
    CUE shares outstanding is up +24.29% year-on-year

    Shares Outstanding 3-Year Change

    +82.93%
    CUE shares outstanding is up +82.93% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.32
    CUE beta is 1.32

    200-day SMA

    $0.73
    CUE price is currently -55.22% below its 200-day simple moving average

    50-day SMA

    $0.59
    CUE price is currently -45.28% below its 50-day simple moving average

    14-Day RSI

    32.27
    CUE 14-day relative strength index is 32.27

    Volume

    7.27
    CUE 30-day relative volume is 7.27

    ATR

    $0.05
    CUE average true range is $0.05

    10-day Historical Volatility

    236.41%
    CUE 10-day historical volatility is 236.41%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $9.29M
    CUE annual revenue is $9.29 million

    Revenue Analysts Estimate

    $7.25M
    CUE annual revenue is currently +28.10% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +69.16%
    CUE annual revenue is up +69.16% year-on-year

    Revenue Sector Percentile

    47.16%
    CUE annual revenue is higher than 47.16% of companies in Healthcare sector

    EPS

    EPS

    -$0.72
    CUE annual earnings per share is -$0.72

    EPS Analysts Estimate

    -$0.41
    CUE annual earnings per share is currently -76.12% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +34.88%
    CUE annual earnings per share is up +34.88% year-on-year

    EPS Sector Percentile

    62.05%
    CUE annual earnings per share is higher than 62.05% of companies in Healthcare sector

    Profit

    Gross Profit

    $6.94M
    CUE annual gross profit is $6.94 million

    Gross Margin

    74.70%
    CUE annual gross profit margin is 74.70%

    Operating Profit

    -$41.59M
    CUE annual operating income is -$41.59 million

    Operating Margin

    -447.86%
    CUE annual operating profit margin is -447.86%

    Net Income

    -$40.67M
    CUE annual net profit is -$40.67 million

    Net Margin

    -437.97%
    CUE annual net profit margin is -437.97%

    Expenses

    Total Expenses

    $50.88M
    CUE annual total expenses is $50.88 million

    Operating Expenses

    $50.88M
    CUE annual total operating expenses is $50.88 million

    Cost Of Goods Sold

    $2.35M
    CUE annual cost of goods sold is $2.35 million

    Selling, General & Administrative Expenses

    $14.59M
    CUE annual SG&A is $14.59 million

    Depreciation & Amortization

    $2.35M
    CUE annual D&A is $2.35 million

    Interest Expense

    $0.00
    CUE annual interest expense is $0.00

    Income Tax

    $0.00
    CUE annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$39.88M
    CUE annual earnings before interest & taxes is -$39.88 million

    EBITDA

    -$37.53M
    CUE annual EBITDA is -$37.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $32.19M
    CUE annual total assets is $32.19 million

    Non Current Assets

    $7.05M
    CUE annual long term assets is $7.05 million

    Current Assets

    $25.14M
    CUE annual total current assets is $25.14 million

    Cash and Cash Equivalents

    $22.46M
    CUE annual cash & cash equivalents is $22.46 million

    Accounts Receivable

    $945.00K
    CUE annual accounts receivable is $945.00 thousand

    Inventory

    $0.00
    CUE annual inventory is $0.00

    Liabilities

    Total Liabilities

    $14.69M
    CUE annual total liabilities is $14.69 million

    Long Term Liabilities

    $1.00M
    CUE annual total long term liabilities is $1.00 million

    Current Liabilities

    $13.69M
    CUE annual current liabilities is $13.69 million

    Accounts Payable

    $2.82M
    CUE annual accounts payable is $2.82 million

    Debt

    Total Debt

    $8.88M
    CUE annual total debt is $8.88 million

    Total Debt 1-Year Change

    -39.6%
    CUE annual total debt is down -39.6% year-on-year

    Long Term Debt

    $1.00M
    CUE annual long term debt is $1.00 million

    Short Term Debt

    $7.87M
    CUE annual short term debt is $7.87 million

    Equity & Capital

    Shareholders Equity

    $17.50M
    CUE annual stockholders equity is $17.50 million

    Book Value

    $17.50M
    CUE annual book value is $17.50 million

    Retained Earnings

    -$341.86M
    CUE annual retained earnings is -$341.86 million

    Working Capital

    $11.45M
    CUE annual working capital is $11.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$36.33M
    CUE annual cash from operations is -$36.33 million

    Cash From Operations 1-Year Change

    +9.09%
    CUE annual cash from operations is up +9.09% year-on-year

    Cash From Investing

    $32.00K
    CUE annual cash from investing is $32.00 thousand

    Cash From Investing 1-Year Change

    -99.87%
    CUE annual cash from investing is down -99.87% year-on-year

    Cash From Financing

    $10.24M
    CUE annual cash from financing is $10.24 million

    Cash From Financing 1-Year Change

    -13.63%
    CUE annual cash from financing is down -13.63% year-on-year

    CAPEX

    CAPEX

    $66.00K
    CUE annual capital expenditures is $66.00 thousand

    CAPEX 1-Year Change

    +100%
    CUE annual capital expenditures is up +100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$36.40M
    CUE annual free cash flow is -$36.40 million

    Free Cash Flow 1-Year Change

    +8.92%
    CUE annual free cash flow is up +8.92% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    74.70%
    CUE annual gross profit margin is 74.70%

    Operating Margin

    -447.86%
    CUE annual operating profit margin is -447.86%

    Net Margin

    -437.97%
    CUE annual net profit margin is -437.97%

    ROA & ROE

    ROA

    -86.80%
    CUE annual return on assets is -86.80%

    ROE

    -149.03%
    CUE annual return on equity is -149.03%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CUE price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CUE price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.93
    CUE price to book ratio is 1.93

    PB Ratio Sector Percentile

    50.64%
    CUE price to book ratio is higher than 50.64% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    3.60
    CUE price to sales ratio is 3.60

    PS Ratio Sector Percentile

    48.21%
    CUE price to sales ratio is higher than 48.21% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $13.08M
    CUE enterprise value is $13.08 million

    Enterprise Value Sector Percentile

    23.76%
    CUE enterprise value is higher than 23.76% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.35
    CUE EV/EBITDA is -0.35

    EV/EBITDA Sector Percentile

    54.58%
    CUE EV/EBITDA is higher than 54.58% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.84
    CUE annual current ratio is 1.84

    Quick Ratio

    1.84
    CUE annual quick ratio is 1.84

    Leverage

    Debt To Equity

    0.51
    CUE annual debt to equity ratio is 0.51

    Interest Coverage Ratio

    -
    CUE annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    CUE piotroski f-score is 3

    Altman Z-Score

    -17.20
    CUE altman z-score is -17.20

    Analyst ratings

    Recent major analysts updates

    Aug 25, 25 LUCID CAPITAL MARKETS
    Buy
    Apr 2, 25 Citizens Capital Markets
    Market Outperform
    Aug 20, 24 Stifel
    Buy
    Jul 26, 24 Piper Sandler
    Overweight
    Jul 26, 24 JMP Securities
    Market Outperform
    Apr 9, 24 Stifel
    Buy
    Apr 9, 24 Oppenheimer
    Outperform
    Apr 3, 24 Piper Sandler
    Overweight
    Mar 13, 24 Jefferies
    Buy
    Nov 6, 23 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with CUE included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Cue Biopharma, Inc.?
    • Does Cue Biopharma, Inc. pay dividends?
    • What sector is Cue Biopharma, Inc. in?
    • What industry is Cue Biopharma, Inc. in?
    • What country is Cue Biopharma, Inc. based in?
    • When did Cue Biopharma, Inc. go public?
    • Is Cue Biopharma, Inc. in the S&P 500?
    • Is Cue Biopharma, Inc. in the NASDAQ 100?
    • Is Cue Biopharma, Inc. in the Dow Jones?
    • When was Cue Biopharma, Inc.'s last earnings report?
    • When does Cue Biopharma, Inc. report earnings?

    What is the ticker symbol for Cue Biopharma, Inc.?

    The ticker symbol for Cue Biopharma, Inc. is NASDAQ:CUE

    Does Cue Biopharma, Inc. pay dividends?

    No, Cue Biopharma, Inc. does not pay dividends

    What sector is Cue Biopharma, Inc. in?

    Cue Biopharma, Inc. is in the Healthcare sector

    What industry is Cue Biopharma, Inc. in?

    Cue Biopharma, Inc. is in the Biotechnology industry

    What country is Cue Biopharma, Inc. based in?

    Cue Biopharma, Inc. is headquartered in United States

    When did Cue Biopharma, Inc. go public?

    Cue Biopharma, Inc.'s initial public offering (IPO) was on January 2, 2018

    Is Cue Biopharma, Inc. in the S&P 500?

    No, Cue Biopharma, Inc. is not included in the S&P 500 index

    Is Cue Biopharma, Inc. in the NASDAQ 100?

    No, Cue Biopharma, Inc. is not included in the NASDAQ 100 index

    Is Cue Biopharma, Inc. in the Dow Jones?

    No, Cue Biopharma, Inc. is not included in the Dow Jones index

    When was Cue Biopharma, Inc.'s last earnings report?

    Cue Biopharma, Inc.'s most recent earnings report was on May 15, 2025

    When does Cue Biopharma, Inc. report earnings?

    The date for Cue Biopharma, Inc.'s next earnings report has not been announced yet
    On this page